Portal de Periódicos da CAPES

EULAR recommendations for the management of knee osteoarthritis

2001; BMJ; Volume: 60; Issue: 5 Linguagem: Inglês

10.1136/ard.60.5.540

1468-2060

Ali S M Jawad,

Antiplatelet Therapy and Cardiovascular Diseases

EULAR recommendations for the management of knee osteoarthritisI welcome the publication of the EULAR recommendations for the management of knee osteoarthritis by the EULAR Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). 1However, it is out of date and has been superseded by other more up to date publications such as the recommendations for the medical management of osteoarthritis of the hip and knee by the American College of Rheumatology (ACR) Subcommittee on Osteoarthritis Guidelines 2 and another review of the medical management of osteoarthritis. 3 The newer COX-1 sparing nonsteroidal anti-inflammatory drugs, rofecoxib and celecoxib are not discussed in the EULAR recommendations, but they have been included in the other reviews. 2 3 My second criticism of the report is that it contains statements such as " SYSADOA... may possess structure modification properties", which is misleading and may lead to widespread use of these drugs in the absence of good evidence.Although the Annals of the Rheumatic Diseases is the oYcial EULAR journal, EULAR reports should be peer reviewed before publication.The ACR recommendations for the management of osteoarthritis of the hip and knee were only accepted in a revised format.